← All Gsk PLC filings

Gsk PLC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
GSK
Gsk PLC
SCHEDULE: FMR LLC Discloses GSK PLC Stake
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.8% of GSK PLC's common stock as of March 31, 2026.
NYSE
GSK
Gsk PLC
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 8.9% Passive Stake in GSK plc
BlackRock, Inc. has filed an amended Schedule 13G, reporting an 8.9% beneficial ownership stake in GSK plc as of December 31, 2024, held for investment purposes.